Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
about
A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatmentDiagnostic utility and correlation of tumor markers in the serum and cerebrospinal fluid of children with intracranial germ cell tumors125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.Validation of 125I-hCG as a marker for elimination of hCG and stability of 125I-hCG after in vivo injection in humans.The role of high-dose chemotherapy in the treatment of testicular cancer.High-dose chemotherapy for germ cell tumors: do we have a model?Survival analysis of children with stage II testicular malignant germ cell tumors treated with surgery or surgery combined with adjuvant chemotherapy.Chemotherapy of metastatic testicular germ cell tumors: relationship of histologic response to size reduction and changes in tumor markers.Testicular tumor markers: Corner-stones in the management of malignant germ cell tumors / Hoden-Tumor-marker: Eckpfeiler in der Behandlung maligner Keimzelltumoren
P2860
Q26862558-14BD0042-F608-4C28-AAF9-14C640F04737Q36479286-6926EDF4-5D25-410F-8EEF-51C2CF1D76DCQ36620523-86B74933-5573-4D2B-BF67-59BA2A98EFE2Q36620536-9AC124E3-C303-4573-AC69-9A8E68F35A18Q38160470-A7B14830-9C2D-4FAF-AFBE-A80FB13284CCQ38253101-C40942CB-5A18-4E9E-9EB7-9FBB49E9E477Q43186477-38695B06-D417-4A83-9050-B22671E86354Q47292232-3A316276-89C7-4798-A8B9-969D42692730Q56594676-1C40E3DA-32DB-424A-ADEE-4A69824B34D1
P2860
Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@en
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@nl
type
label
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@en
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@nl
prefLabel
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@en
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@nl
P2093
P1433
P1476
Serum tumor marker decline is ...... osfamide salvage chemotherapy.
@en
P2093
Mazumdar M
Nisselbaum J
P304
P356
10.1002/1097-0142(19940515)73:10<2520::AID-CNCR2820731012>3.0.CO;2-R
P407
P577
1994-05-01T00:00:00Z